146 related articles for article (PubMed ID: 25312990)
41. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes.
Chu KP; Murphy JD; La TH; Krakow TE; Iagaru A; Graves EE; Hsu A; Maxim PG; Loo B; Chang DT; Le QT
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1521-7. PubMed ID: 22270168
[TBL] [Abstract][Full Text] [Related]
43. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of preoperative intratumoral FDG uptake heterogeneity in early stage uterine cervical cancer.
Chung HH; Kang SY; Ha S; Kim JW; Park NH; Song YS; Cheon GJ
J Gynecol Oncol; 2016 Mar; 27(2):e15. PubMed ID: 26768781
[TBL] [Abstract][Full Text] [Related]
45. Volume-based assessment by (18)F-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer.
Hyun SH; Ahn HK; Kim H; Ahn MJ; Park K; Ahn YC; Kim J; Shim YM; Choi JY
Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):50-8. PubMed ID: 23948859
[TBL] [Abstract][Full Text] [Related]
46. Prognostic significance of novel ¹⁸F-FDG PET/CT defined tumour variables in patients with oesophageal cancer.
Foley KG; Fielding P; Lewis WG; Karran A; Chan D; Blake P; Roberts SA
Eur J Radiol; 2014 Jul; 83(7):1069-1073. PubMed ID: 24794862
[TBL] [Abstract][Full Text] [Related]
47. Deep learning analysis using FDG-PET to predict treatment outcome in patients with oral cavity squamous cell carcinoma.
Fujima N; Andreu-Arasa VC; Meibom SK; Mercier GA; Salama AR; Truong MT; Sakai O
Eur Radiol; 2020 Nov; 30(11):6322-6330. PubMed ID: 32524219
[TBL] [Abstract][Full Text] [Related]
48. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
Satoh Y; Onishi H; Nambu A; Araki T
Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
[TBL] [Abstract][Full Text] [Related]
49. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
50. Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Liao S; Penney BC; Wroblewski K; Zhang H; Simon CA; Kampalath R; Shih MC; Shimada N; Chen S; Salgia R; Appelbaum DE; Suzuki K; Chen CT; Pu Y
Eur J Nucl Med Mol Imaging; 2012 Jan; 39(1):27-38. PubMed ID: 21946983
[TBL] [Abstract][Full Text] [Related]
51. Confirmation of the prognostic value of pretherapeutic tumor SUR and MTV in patients with esophageal squamous cell carcinoma.
Hofheinz F; Li Y; Steffen IG; Lin Q; Lili C; Hua W; van den Hoff J; Zschaeck S
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1485-1494. PubMed ID: 30949816
[TBL] [Abstract][Full Text] [Related]
52. Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative ¹⁸F-FDG PET/CT in Patients with Pancreatic Cancer.
Lee JW; Kang CM; Choi HJ; Lee WJ; Song SY; Lee JH; Lee JD
J Nucl Med; 2014 Jun; 55(6):898-904. PubMed ID: 24711649
[TBL] [Abstract][Full Text] [Related]
53. Prognostic value of metabolic tumor volume measured by 18F-FDG PET/CT in advanced-stage squamous cell carcinoma of the larynx and hypopharynx.
Park GC; Kim JS; Roh JL; Choi SH; Nam SY; Kim SY
Ann Oncol; 2013 Jan; 24(1):208-14. PubMed ID: 23002280
[TBL] [Abstract][Full Text] [Related]
54. Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
La TH; Filion EJ; Turnbull BB; Chu JN; Lee P; Nguyen K; Maxim P; Quon A; Graves EE; Loo BW; Le QT
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1335-41. PubMed ID: 19289263
[TBL] [Abstract][Full Text] [Related]
55. Value of Intratumoral Metabolic Heterogeneity and Quantitative
Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM
AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078
[No Abstract] [Full Text] [Related]
56. Can adaptive threshold-based metabolic tumor volume (MTV) and lean body mass corrected standard uptake value (SUL) predict prognosis in head and neck cancer patients treated with definitive radiotherapy/chemoradiotherapy?
Akagunduz OO; Savas R; Yalman D; Kocacelebi K; Esassolak M
Nucl Med Biol; 2015 Nov; 42(11):899-904. PubMed ID: 26275933
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
58. Whole-Body Metabolic Tumor Volume, as Determined by (18)F-FDG PET/CT, as a Prognostic Factor of Outcome for Patients With Breast Cancer Who Have Distant Metastasis.
Son SH; Lee SW; Jeong SY; Song BI; Chae YS; Ahn BC; Lee J
AJR Am J Roentgenol; 2015 Oct; 205(4):878-85. PubMed ID: 26204115
[TBL] [Abstract][Full Text] [Related]
59. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
60. Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):721-6. PubMed ID: 23921497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]